Related Experiment Videos
Nonmutagenic action of cannabinoids in vitro
Pharmacology
|January 1, 1978
Summary
Delta9-tetrahydrocannabinol (THC) did not show mutagenic effects in microbial or eukaryotic tests. Studies confirmed THC does not induce gene mutations or DNA damage in various in vitro systems.
Area of Science:
- Toxicology
- Genetics
- Molecular Biology
Background:
- Delta9-tetrahydrocannabinol (THC) is a primary psychoactive component of cannabis.
- Understanding its genotoxic potential is crucial for assessing health risks.
Purpose of the Study:
- To evaluate the mutagenic and genotoxic effects of delta9-tetrahydrocannabinol (THC) in vitro.
- To assess THC's impact on DNA repair mechanisms.
Main Methods:
- Bacterial reverse mutation assays (Ames test) using Salmonella typhimurium strains TA98 and TA100, with and without S9 activation.
- In vitro assays using cultured human fibroblasts (including Xeroderma pigmentosum cells) to assess cell survival, chromosomal aberrations, and DNA repair synthesis.
- Testing of related cannabinoids like 11-OHdelta9-THC, cannabinol, and cannabidiol.
Main Results:
- THC did not induce gene mutations in Salmonella typhimurium strains TA98 or TA100.
- No increase in chromosomal breaks or exchanges was observed in cultured fibroblasts exposed to THC.
- THC and related cannabinoids did not induce unscheduled DNA repair synthesis and did not inhibit UV-induced DNA repair.
Conclusions:
- Under the tested conditions, delta9-tetrahydrocannabinol (THC) does not exhibit mutagenic or genotoxic activity in microbial and eukaryotic in vitro systems.
- THC does not appear to interfere with essential DNA repair mechanisms.